Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Backgrounds: The relationship between sarcopenia, characterized by loss of muscle mass and strength, and survival outcomes of esophageal cancer is controversial. This study aimed to assess the effect of sarcopenia and skeletal muscle loss on overall survival (OS) and recurrence-free survival (RFS) o...

Full description

Bibliographic Details
Main Authors: Han Gyul Yoon, Dongryul Oh, Yong Chan Ahn, Jae Myoung Noh, Hongryull Pyo, Won Kyung Cho, Yun Mi Song, Minsu Park, Na Young Hwang, Jong-Mu Sun, Hong Kwan Kim, Jae Ill Zo, Young Mog Shim
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Cancers
Subjects:
esophageal cancer
neoadjuvant chemoradiotherapy
sarcopenia
skeletal muscle loss
nutrition
inflammation
Online Access:https://www.mdpi.com/2072-6694/12/4/925

Internet

https://www.mdpi.com/2072-6694/12/4/925

Similar Items